Facility
Serum Institute Hadapsar Facility
Primary manufacturing campus; produces bulk of SII's 1.9B doses/year. Houses multiple vaccine production lines for polio, measles, DTP, BCG, COVID. Single-site concentration risk for 60% of global vaccine dose supply.
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories